Top 50 Health Care VC Funds & Investors in United Kingdom (September 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
SFC Capital
VC Fund
|
103 | United Kingdom, United States, Canada | Pre-Seed, Seed | Artificial Intelligence, Software, Information Technology | $126k–$2M |
|
Parkwalk Advisors
VC Fund
|
76 | United Kingdom, United States, Philippines | Seed, Series A, Series B | Biotechnology, Health Care, Software | $991k–$45M |
|
Scottish Enterprise
VC Fund
|
75 | United Kingdom, United States, Switzerland | Grant, Seed, Venture - Series Unknown | Biotechnology, Software, Health Care | $119k–$8.4M |
|
UK Innovation & Science Seed Fund
VC Fund
|
68 | United Kingdom, United States | Seed, Series A | Biotechnology, Health Care, Medical | $482k–$14M |
|
Oxford Science Enterprises
VC Fund
|
63 | United Kingdom, United States, Finland | Seed, Series A, Series B | Health Care, Biotechnology, Software | $1.3M–$168M |
|
Future Planet Capital
VC Fund
|
60 | United Kingdom, United States, Singapore | Seed, Convertible Note | Biotechnology, Health Care, Software | $670k–$5.1M |
|
Business Growth Fund
VC Fund
|
56 | United Kingdom, Ireland, United States | Venture - Series Unknown, Private Equity, Series A | Software, Information Technology, Manufacturing | $3.4M–$27M |
|
Development Bank of Wales
VC Fund
|
55 | United Kingdom, Australia, United States | Seed, Debt Financing, Venture - Series Unknown | Software, Health Care, Manufacturing | $19k–$5.4M |
|
Deepbridge Capital
VC Fund
|
49 | United Kingdom, Spain, Australia | Seed, Venture - Series Unknown, Series A | Health Care, Biotechnology, Medical | $142k–$15M |
|
Scottish Investment Bank
VC Fund
|
48 | United Kingdom, United States, France | Venture - Series Unknown, Seed, Series A | Software, Biotechnology, Health Care | $244k–$7.5M |
|
Northstar Ventures
VC Fund
|
47 | United Kingdom, United States, Indonesia | Seed, Venture - Series Unknown, Series A | Software, Health Care, Information Technology | $43k–$10M |
|
Oxford Technology Management
VC Fund
|
46 | United Kingdom, United States | Seed, Series A | Biotechnology, Health Care, Software | $33k–$8.5M |
|
AlbionVC
VC Fund
|
42 | United Kingdom, United States, France | Series A, Seed | Software, Information Technology, Health Care | $2.4M–$19M |
|
Mercia Fund Managers
VC Fund
|
42 | United Kingdom, United States, Hungary | Seed, Venture - Series Unknown, Series A | Software, Health Care, Biotechnology | $250k–$14M |
|
Innovate UK
VC Fund
|
40 | United Kingdom, United States, Ireland | Grant, Seed, Pre-Seed | Health Care, Biotechnology, Software | $57k–$3.5M |
|
SyndicateRoom
VC Fund
|
38 | United Kingdom, United States, India | Seed, Equity Crowdfunding | Health Care, Software, Medical | $248k–$2.7M |
|
Octopus Ventures
VC Fund
|
37 | United Kingdom, United States, Germany | Series A, Seed, Series B | Software, Artificial Intelligence, Health Care | $2.1M–$43M |
|
Mercia Asset Management
VC Fund
|
34 | United Kingdom, United States | Venture - Series Unknown, Series A, Seed | Software, Information Technology, Health Care | $576k–$13M |
|
IP Group
VC Fund
|
34 | United Kingdom, United States, Australia | Seed, Series A | Health Care, Biotechnology, Therapeutics | $456k–$30M |
|
Cambridge Angels group
VC Fund
|
34 | United Kingdom, United States, Estonia | Seed, Series A, Pre-Seed | Software, Health Care, Biotechnology | $193k–$9.5M |
|
Salica
VC Fund
|
33 | United Kingdom, United States, Germany | Seed, Secondary Market, Series A | Software, Information Technology, Health Care | $645k–$346M |
|
SOSV
VC Fund
|
33 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
Catapult Ventures
VC Fund
|
33 | United Kingdom, United States, Israel | Seed, Venture - Series Unknown | Health Care, Biotechnology, Medical | $150k–$5.6M |
|
Foresight Group
VC Fund
|
32 | United Kingdom, United States, Ireland | Private Equity, Seed | Software, Manufacturing, Information Technology | $648k–$9.4M |
|
Praetura Ventures
VC Fund
|
31 | United Kingdom, Australia, Germany | Venture - Series Unknown, Seed | Software, Information Technology, Artificial Intelligence | $261k–$7.2M |
|
Archangels
VC Fund
|
31 | United Kingdom, United States | Venture - Series Unknown, Seed | Software, Health Care, Biotechnology | $867k–$6.3M |
|
Calm/Storm VC
VC Fund
|
31 | United Kingdom, Germany, Austria | Seed, Pre-Seed, Series A | Health Care, Wellness, Software | $538k–$18M |
|
Newable Private Investing
VC Fund
|
31 | United Kingdom, United States | Seed, Series A | Software, Health Care, Biotechnology | $196k–$5.6M |
|
Ascension
VC Fund
|
29 | United Kingdom, United States, Italy | Seed, Pre-Seed | Software, FinTech, Internet | $229k–$4.1M |
|
Redbus Ventures
VC Fund
|
29 | United Kingdom, United States, Australia | Seed, Series A, Pre-Seed | FinTech, E-Commerce, Health Care | $323k–$23M |
|
Kelvin Capital
VC Fund
|
29 | United Kingdom, United States | Seed, Venture - Series Unknown | Health Care, Biotechnology, Manufacturing | $163k–$4.5M |
|
Oxford Capital
VC Fund
|
28 | United Kingdom, United States, France | Seed, Series A | Software, Health Care, Biotechnology | $1.7M–$16M |
|
Entrepreneurs First
VC Fund
|
27 | United Kingdom, United States, India | Pre-Seed, Seed, Series A | Artificial Intelligence, Software, Information Technology | $54k–$41M |
|
Antler
VC Fund
|
27 | Singapore, Australia, United Kingdom | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, Information Technology | $100k–$29M |
|
Epidarex Capital
VC Fund
|
26 | United Kingdom, United States, Germany | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $551k–$48M |
|
Techstart Ventures
VC Fund
|
26 | United Kingdom, Ireland, United States | Seed, Pre-Seed | Software, Information Technology, Health Care | $197k–$4M |
|
The FSE Group
VC Fund
|
26 | United Kingdom, United States, Canada | Seed, Debt Financing | Software, Manufacturing, Information Technology | $106k–$2.3M |
|
O2h Ventures
VC Fund
|
26 | United Kingdom, Hungary | Seed, Venture - Series Unknown, Series A | Biotechnology, Health Care, Pharmaceutical | $603k–$25M |
|
GM&C Life Sciences Fund
VC Fund
|
25 | United Kingdom, Italy, Germany | Seed, Series A | Health Care, Biotechnology, Medical | $94k–$4.2M |
|
Par Equity
VC Fund
|
24 | United Kingdom, United States, Brazil | Venture - Series Unknown, Seed | Software, Manufacturing, Information Technology | $113k–$4.3M |
|
Kindred Capital
VC Fund
|
24 | United Kingdom, United States, Germany | Seed, Series A, Series B | Software, Biotechnology, Health Care | $1.4M–$73M |
|
Hoxton Ventures
VC Fund
|
24 | United Kingdom, United States, Canada | Seed, Series A, Series B | Artificial Intelligence, Software, Health Care | $1.9M–$35M |
|
Midlands Engine Investment Fund
VC Fund
|
24 | United Kingdom, United States, Portugal | Debt Financing, Seed | Software, Health Care, Manufacturing | $250k–$2.7M |
|
24 Haymarket
VC Fund
|
23 | United Kingdom, United States | Venture - Series Unknown, Seed, Series A | Health Care, Software, Biotechnology | $107k–$16M |
|
LocalGlobe
VC Fund
|
23 | United Kingdom, United States, France | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Information Technology | $1M–$33M |
|
Syncona Partners LLP
VC Fund
|
22 | United Kingdom, United States, Switzerland | Series A, Series B, Seed | Biotechnology, Medical, Health Care | $1.9M–$156M |
|
Cambridge Innovation Capital
VC Fund
|
21 | United Kingdom, United States, Ireland | Series A, Series B, Seed | Biotechnology, Health Care, Medical | $2M–$73M |
|
Downing Ventures
VC Fund
|
21 | United Kingdom, United States, Israel | Seed, Venture - Series Unknown, Series A | Software, Health Care, Information Technology | $501k–$14M |
|
Maven Capital Partners
VC Fund
|
21 | United Kingdom, United States, Germany | Venture - Series Unknown, Seed, Private Equity | Software, Information Technology, SaaS | $648k–$15M |
|
Empirical Ventures
VC Fund
|
20 | United Kingdom | Seed, Pre-Seed | Biotechnology, Medical, Health Care | $924k–$5.8M |
| Access all 3347 VC funds in United Kingdom Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Pre-Seed, Seed
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 754
- Round size: Seed $126k–$2M; Pre-Seed $170k–$858k
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — raised $1.9M in 2019
Portfolio highlights
- Anemo Labs — We develop highly selective polymer-based sensors to detect gas VOCs in the ppb range, in real-time. We combine custom hardware with Machine Learning to characterize smells
- FlairMakers — FlairMakers provides a digital talent platform connecting hospitality businesses with vetted freelance professionals.
- Pure Capture Innovations — Pure Capture Innovations develop the next generation of sustainable adsorbents to solve the emerging PFAS crisis, removing 'forever chemicals' contaminating our water and affecting public health
Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Philippines
Investor stats
- Total investments: 325
- Round size: Seed $991k–$4.9M; Series A $1.6M–$14M; Series B $2.2M–$45M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
- K3 Metrology — K3 Metrology is a specialist metrology company commercialising laser‑based 3D coordinate measurement technology developed at the National Physical Laboratory. The company’s platform is designed to provide high‑accuracy, uncertainty‑aware dimensional data in large‑volume industrial environments, supporting inspection and assembly processes inadvanced manufacturing. Its systems integrate into production workflows where traceable measurements are required across complex geometries and large structures. The technology is applied in sectors such as aerospace, defence, and nuclear, where dimensional integrity and process control are critical.
- MoA Technology — We harness the principles of natural selection to accelerate discovery for better, safer herbicides so farmers can continue to feed the world.
Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Grant, Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 395
- Round size: Seed $387k–$4.3M; Grant $119k–$4.2M; Venture - Series Unknown $726k–$8.4M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Kenoteq — Discover Kenoteq, pioneering the sustainable construction revolution with our innovative, ultra low-carbon building materials.
- QuickBlock — QUICKBLOCK delivers training environments, deployable infrastructure and force protection solutions for defence and security organisations worldwide.
- Singular Photonics — Singular Photonics is a startup that creates SPAD-based image sensors.
UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 148
- Round size: Seed $482k–$5.9M; Series A $2.9M–$14M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- KVector — KVector creates communication and sensing solutions with high gain and efficiency from X-band to sub-terahertz bands and beyond. Modern antenna systems are built by KVector.
- Zentraxa — NATURE ENGINEERED FOR PURPOSE Through millions of years of evolution, nature has found solutions to the most difficult problems. Inspired by the diversity of nature, we precision engineer bespoke biomaterials to meet the toughest challenges across
- Singular Machines — Singular Machines is an engineering automation company that provides solutions to engineering issues.
Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking onchallenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Finland
Investor stats
- Total investments: 205
- Round size: Seed $1.3M–$12M; Series A $6.3M–$45M; Series B $9.1M–$168M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $299M in 2022
Portfolio highlights
- MCatalysis — Manufacturing drop-in liquid commodities from distributed hydrocarbon feedstocks below commodity cost with small modular refining.
- Caudal Energy — Porpoise Power develops a tidal energy system using oscillating hydrofoil technology inspired by dolphin swimming mechanics.
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Brilliant Ideas. Brilliant People. Brilliant Minds.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note
- Geography: United Kingdom, United States, Singapore
Investor stats
- Total investments: 281
- Round size: Seed $670k–$5.1M
- Lead/follow: 5% lead, 95% follow
- Last fund: Likely still investing — raised $23M in 2022
Portfolio highlights
- Unloq AI — Unloq is a Decision Intelligence Platform that turns your company data and live market signals into governed strategic recommendations. Approved, tracked, measured.
- Nourished — At Nourished we create innovative. personalised nutrition stacks that are truly unique to you. Vegan, waste-free and always made to order.
- K3 Metrology — K3 Metrology is a specialist metrology company commercialising laser‑based 3D coordinate measurement technology developed at the National Physical Laboratory. The company’s platform is designed to provide high‑accuracy, uncertainty‑aware dimensional data in large‑volume industrial environments, supporting inspection and assembly processes inadvanced manufacturing. Its systems integrate into production workflows where traceable measurements are required across complex geometries and large structures. The technology is applied in sectors such as aerospace, defence, and nuclear, where dimensional integrity and process control are critical.
BGF is the most active equity investor in the UK and Ireland, providing long-term, minority investment to growing companies.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Venture - Series Unknown, Private Equity, Series A
- Geography: United Kingdom, Ireland, United States
Investor stats
- Total investments: 561
- Round size: Series A $4.1M–$21M; Private Equity $6.4M–$27M; Venture - Series Unknown $3.4M–$16M
- Lead/follow: 86% lead, 14% follow
- Last fund: Likely still investing — raised $97M in 2022
Portfolio highlights
- Inoapps —
- Flowline —
- TMT ID — A leading provider of global mobile and device intelligence. We power leading identity providers, A2P SMS messaging companies and financial organisations.
Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Debt Financing, Venture - Series Unknown
- Geography: United Kingdom, Australia, United States
Investor stats
- Total investments: 288
- Round size: Seed $327k–$3M; Debt Financing $19k–$3.7M; Venture - Series Unknown $350k–$5.4M
- Lead/follow: 62% lead, 38% follow
- Last fund: May invest from a new fund soon — raised $27M in 2018
Portfolio highlights
- nisien.ai — Nisien.ai uses industry-leading AI for the detection, defence and resolution of online harm, for better online safety and digital wellbeing.
- Design and Supply — Design and Supply are specialist manufacturers and suppliers of Industrial Steel Doors and Architectural Products.
- Outlook Expeditions — Ready. For Life.
Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United Kingdom, Spain, Australia
Investor stats
- Total investments: 91
- Round size: Seed $142k–$2.4M; Series A $2M–$15M; Venture - Series Unknown $259k–$2.8M
- Lead/follow: 69% lead, 31% follow
- Last fund: Likely still investing — raised $1.4M in 2022
Portfolio highlights
- upLYFT — upLYFT creates next-generation wearable technology that continuously analyses biomechanics and movement biomarkers, giving athletes, clinicians and physiotherapists precise insight into performance, recovery and injury risk.
- GeneralPractice.AI — GeneralPractice.AI - Infusing Artificial Intelligence into the Fabric of General Practice
- Spotlight Pathology — Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers.
Speak with our team, who can help you find sources of finance, engage with funders and secure investment to grow your business.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 276
- Round size: Seed $331k–$3.1M; Series A $1.7M–$7.5M; Venture - Series Unknown $244k–$4.1M
- Lead/follow: 13% lead, 87% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
- IOTech — Discover IOTech Systems. Deploy, manage, and scale AI-driven, data-rich industrial systems at the edge with our open edge data platform.
- Administrate — Manage instructor-led training with Administrate. Plan, schedule, communicate, resolve issues, and report on training operations from one platform.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Northstar Ventures invests venture capital in early and later stage, high growth companies tackling global challenges, focusing on climate tech and healthy ageing.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United Kingdom, United States, Indonesia
Investor stats
- Total investments: 238
- Round size: Seed $43k–$2M; Series A $295k–$10M; Venture - Series Unknown $261k–$3.8M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — raised $20M in 2024
Portfolio highlights
- H2CHP — H2CHP's Free Piston Engine Technology enables your transition to green energy with the reliability & confidence of fuel flexibility.
- Land Digital — Land Digital is a tech, web design, web creation, content marketing, digital marketing, SEO, and mobile application agency.
- Advanced Electric Machines — Our magnet free motors help manufacturers build more sustainable vehicles and products. See how we can help you today.
Oxford Technology's SEIS fund and EIS fund enable private investors to access high growth technology startup opportunities and support UK innovation. SEIS and EIS tax reliefs offer downside protection, whilst gains can be tax free.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 111
- Round size: Seed $33k–$2.2M; Series A $786k–$8.5M
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — last raise in 2012
Portfolio highlights
- OrganOx — OrganOx Limited was founded in 2008 to exploit normothermic preservation technology invented by Prof Peter Friend and colleagues and further developed by Prof Constantin Coussios at the University of Oxford.
- CryoLogyx — CryoLogyx Ltd. trading as CryoLogyx registered in England and Wales 13078280. VAT registered 373846855. Our registered office address is CryoLogyx Ltd, The Venture Centre, Sir William Lyons Road, Coventry, CV4 7EZ.
- Metacarpal — Metacarpal design upper-limb prosthetics without compromise. We aim to make the most robust, functional hand prosthesis that people love wearing because it works so effectively and looks so beautiful. Be proud to show your artificial side!
AlbionVC supports visionary founders and technologies with long-term capital and scale-up know-how. Founded in 1996, it was amongst the first to back leading global success stories such as Booking.com, Egress, Quantexa and Oviva. With £1bn in AUM and over 100 exits successfully realised, it funds venture breakthroughs that drive real outcomes forfounders, investors and society. AlbionVC is the technology investment arm of Albion Capital Group, which is authorised and regulated by the Financial Conduct Authority. For more information please visit: https://albion.vc/
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Series A, Seed
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 179
- Round size: Seed $2.4M–$12M; Series A $3.9M–$19M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- geoSurge — Customers don't search. They ask.
- Oshen — Oshen is a technology enterprise that creates miniature autonomous sailboats designed for persistent, wide-area ocean tracking.
- Gravitee — Open Source API Management Platform - Gravitee
Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United Kingdom, United States, Hungary
Investor stats
- Total investments: 144
- Round size: Seed $250k–$2.1M; Series A $2M–$14M; Venture - Series Unknown $406k–$5.3M
- Lead/follow: 67% lead, 33% follow
- Last fund: May invest from a new fund soon — last raise in 2013
Portfolio highlights
- Ben — Ben is the all-in-one platform for any company to personalise benefits and reward.Our secret? Marrying a modern software (SaaS) platform with per-employee Mastercards and financial infrastructure. That’s how Ben instantly adds employee choice to your existing benefits, unlocks access to hundreds of additional options through Ben Card, all whilesaving you time and money.
- Distil.ai — Distil.ai is a software platform that helps businesses to understand their customers’ behavior and identify buying signals.
- MRC Engineering — MRC Engineering Providing a different option to the UK Rail Industry for Telecoms Design. Nationally renowned design specialists who provide extraordinary ...
Innovate UK is part of the UK Research and Innovation .
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Grant, Seed, Pre-Seed
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 1215
- Round size: Seed $143k–$3.5M; Grant $62k–$1.8M; Pre-Seed $57k–$1.3M
- Lead/follow: 76% lead, 24% follow
Portfolio highlights
- KVector — KVector creates communication and sensing solutions with high gain and efficiency from X-band to sub-terahertz bands and beyond. Modern antenna systems are built by KVector.
- Anemo Labs — We develop highly selective polymer-based sensors to detect gas VOCs in the ppb range, in real-time. We combine custom hardware with Machine Learning to characterize smells
- Athernal Bio — Athernal Bio is developing targeted immunotherapies to treat blood cancer precursor conditions before cancers become established.
SyndicateRoom is fintech company made up of data-scientists, investment professionals, software developers and marketers with one mission: to be an early investor in every British startup success story.To do this – and make fund investors money – we don’t try to spot the next Big Thing.Instead, we apply a data-driven model to portfolioconstruction; a repeatable process designed to maximise returns and minimise risk for fund investors. As such, we build startup portfolios that don’t attempt to predict the future; they work to stack the odds in investors’ favour.Our fund, Access EIS, aims to build investors a diversified portfolio of 50+ companies by co‑investing exclusively with some of the UK’s best-performing angel investors.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Equity Crowdfunding
- Geography: United Kingdom, United States, India
Investor stats
- Total investments: 149
- Round size: Seed $390k–$2.7M; Equity Crowdfunding $248k–$1.9M
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- ManaMind — Human-like testing at machine scale. ManaMind delivers fully autonomous QA testing for video games - zero-shot, no code access, infinitely scalable.
- urfuture — Urfuture connects young job seekers with entry-level employment opportunities through a mobile application. The system uses behavioural and data-driven matching to suggest roles aligned with user profiles and preferences. It includes tools for building a single profile that can be used across multiple job applications, reducing repeated CVcreation. The platform supports job discovery, application tracking, and direct communication between candidates and employers through messaging and video features. Urfuture also enables employers to post roles, review matched candidates, and manage hiring workflows in a centralized system.
- Joyvié — Joyvié Health designs medical continence products focused on managing severe faecal incontinence. The company is developing a patent-pending class of non-invasive faecal management briefs that prevent stool from contacting the skin. By separating waste from the body, the underwear aims to lower the risk of skin breakdown and secondary infectionwhile reducing the physical and emotional strain on caregivers. Joyvié Health works with care providers to pilot its products in real-world care environments and gather clinical and user feedback. Its offering is intended for adults with continence needs in institutional and home care settings, and for professionals responsible for continence care. The company also engages with investors and partners to advance product development and clinical evaluation.
We provide venture capital investment for the people, ideas and industries that will change the world. Learn about what we do and the kind of founders we back.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Seed, Series B
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 432
- Round size: Seed $2.1M–$13M; Series A $3.8M–$22M; Series B $7.5M–$43M
- Lead/follow: 57% lead, 43% follow
- Last fund: May invest from a new fund soon — raised $108M in 2019
Portfolio highlights
- Grasp — Grasp is the world's first AI analyst for finance professionals. Our AI analyst automates company and market research for investment banks, private equity firms, and management consulting firms across the world.
- Resolutiion — Resolutiion provides AI-powered software for managing commercial conflict, delivery risk, and business relationship performance. The platform supports organizations with dispute detection, workflow automation, contract monitoring, issue resolution, and operational risk management across customers, suppliers, workforce teams, and commercialpartnerships. Its system uses AI-driven analysis to identify relationship friction, monitor delivery performance, and support structured resolution processes. Resolutiion also provides commercial intelligence tools, reporting, and collaboration features for enterprise delivery and governance management.
- Monkey Bizness — Monkey Bizness is the largest provider of indoor family entertainment centres in the UK. Each centre includes a children's soft play area and is designed to provide a safe, clean and fun environment in which parents and children can feel comfortable. Monkey Bizness' centres provide a setting that encourages children to express themselvesthrough creativity and play as well as providing fresh and nutritious food to keep kids happy and healthy.Monkey Bizness currently has centres in eight locations: Lewes, Gosport, Poole, Sheffield, Stevenage, Hull Edinburgh and Glasgow.
Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Venture - Series Unknown, Series A, Seed
- Geography: United Kingdom, United States
Investor stats
- Total investments: 108
- Round size: Seed $576k–$3.2M; Series A $2.2M–$13M; Venture - Series Unknown $659k–$12M
- Lead/follow: 63% lead, 37% follow
- Last fund: May invest from a new fund soon — raised $38M in 2018
Portfolio highlights
- StratoBayes — Automated stratigraphic correlation with quantified uncertainty, built on Bayesian statistical inference.
- Camena Bioscience — Camena Bioscience is a synthetic biology company that develops tools to engineer new synthetic biology applications. It has engineered new nucleic acid synthesis technology which improves the quality and speed of synthesis. Its multi-enzymatic technology takes one approach to DNA, RNA, and XNA synthesis, offering increased accuracy over existingPhosphoramidite synthesis technology.Camena Bioscience was founded in 2016 and is headquartered in Cambridge.
- Warwick Acoustics Ltd — Warwick Acoustics is a UK-based technology company specialising in the development of HighRes Audio solutions for the automotive and headphone markets based on its patented High Precision Electrostatic Laminate technology (HPELs). Their ultra thin, lightweight HPELs deliver audiophile performance across a bandwidth several octaves greater thantraditional moving coil speakers in a form factor that is less than one quarter the weight, and one tenth of the thickness. In addition, HPELs offer designers unparalleled flexibility to shaped and form a speaker to individual design requirements.
IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Therapeutics
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Australia
Investor stats
- Total investments: 214
- Round size: Seed $456k–$8.5M; Series A $2.4M–$30M
- Lead/follow: 21% lead, 79% follow
- Last fund: Likely actively investing — fresh fund, raised $50M in 2026
Portfolio highlights
- Eight19 — Eight19, located in Cambridge, UK, develops and manufactures plastic photovoltaics for energy harvesting, for the internet of things and for off-grid applications. Through the innovative use of industry-standard, high-volume, roll-to-roll processes and solution-based organic photoactive materials, the company has a highly cost-effective route forscaling-up its technology to supply the largest markets. Eight19 is currently producing modules on a small scale for commercial partners with applications in indoor energy harvesting for wireless sensor and controllers, signage and display, and outdoor power for portable electronics. Our plastic PV modules benefit from flexibility, thinness, light-weight and robustness.
- Slamcore — Positioning, mapping and perception | State-of-the-art visual SLAM turns sensor data into actionable, spatial understanding for your vehicles.
- Mach42 — Machine Discovery is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity.
The Cambridge Angels are a group of high-net worth investors who have proven experience as successful entrepreneurs in internet, software, technology and bio-technology. Members invest in and mentor high quality start-up and early-stage companies in these sectors in the Cambridge (UK) area and throughout the UK.Typical funding requirements thatthe Cambridge Angels meet are in the range of £50,000 to £500,000 - although it is worth noting that several of their portfolio companies have received more than £1m in funding from their Members over several funding rounds.Their Members have been responsible for a large number of the “Cambridge Phenomenon” success stories over recent years. Therefore, in addition to providing funding for early-stage companies, the Cambridge Angels also offer start-ups the considerable benefit of a wide range of expertise, contacts and directly relevant experience in establishing and growing entrepreneurial businesses successfully.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, United States, Estonia
Investor stats
- Total investments: 142
- Round size: Seed $382k–$3M; Pre-Seed $193k–$1.2M; Series A $2M–$9.5M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
- Orthofuse — Orthofuse designs and manufacturers advance orthopaedic solutions using 3D printing technology. Their focus is on bringing precision and simplicity to complex surgical procedures, creating implants and systems that fit naturally into a surgeon's workflow while delivering dependable outcomes.
- Singular Photonics — Singular Photonics is a startup that creates SPAD-based image sensors.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Founded as an investment firm focusing on the most promising startups, we have evolved into a unique set of private market funds investing globally in equity and debt across complementary sectors and stages. We fuse traditional values with a contemporary approach and balance exacting processes with the agility to capture commercial opportunity andcompelling investment returns. Our continuous search for new opportunities has led us to create a balanced collection of complementary funds and relationships.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Secondary Market, Series A
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 247
- Round size: Seed $645k–$4.3M; Series A $3.9M–$19M; Secondary Market $60M–$346M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely actively investing — fresh fund, raised $12M in 2026
Portfolio highlights
- Moneybox — Moneybox is the simple way to save, invest, buy your first home, and combine your old pensions - all with one award-winning app. Download now.
- CameraMatics — Digitize fleet management to optimize performance. Onboard sensors, smart cameras, & apps to mitigate risk, manage safety & achieve sustainability goals.
- Modern Milkman — Modern Milkman is a Yorkshire-based milk delivery company.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
The team behind Catapult Ventures are among the most experienced venture capital investors in the UK.Their experience spans a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software, as well as all stages: from start-ups and pre-revenue IP developers to company floatation and billions of poundsin revenue. Their administration team is equally experienced with each member having more than 10 years experience in a venture capital environment.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, Israel
Investor stats
- Total investments: 105
- Round size: Seed $150k–$5.6M; Venture - Series Unknown $370k–$5M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Path Robotics — We create manufacturing robots that autonomously scan, position, and weld your parts without the need for skilled welders or robot programmers.
- Pickle Robot — We make robots that unload trucks without retrofitting the warehouse
- Anello Photonics — Anello Photonics is a technology company developing a silicon photonic optical gyroscope to navigate, position, and motion track autonomous applications in challenging GPS-jammed and spoofed environments. The company's technology portfolio spans over 28 issued patents, and over 44 pending patents, and includes an AI-based sensor fusion engine.It serves the robotics, defense, construction, agriculture, and autonomous vehicles industries.
Foresight Group is a listed infrastructure and private equity investment manager which has been managing funds on behalf of institutions and retail clients for more than 35 years. Foresight has over £7.2 billion of assets under management across a number of funds on behalf of some of the world’s largest institutional investors, family offices,private and high net-worth individuals and retail investors. Foresight's investment strategies are underpinned by a strong environmental, social & governance (“ESG”) focus, which increasingly meets the demands of today’s investors and ensures we are consistently working towards creating a sustainable legacy for future generations.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Private Equity, Seed
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 221
- Round size: Seed $648k–$9.4M; Private Equity $2.1M–$8.3M
- Lead/follow: 65% lead, 35% follow
- Last fund: Likely actively investing — fresh fund, raised $120M in 2025
Portfolio highlights
- Vertal — Vertal is a food waste recycling company
- Welding Engineers — Welding Engineers has been in business since 1966 and is a major independent door company specialising in the manufacture, installation, repair and maintenance of all types of Industrial Doors and Shutters, Steel Fabrication, Lift Gates and Shutters, Industrial Roofing and Structural Glazing.
- Industrial Engineering Plastics — Industrial Engineering Plastics delivers specialist thermoplastic fabrication, DW154-compliant ductwork, machining, and plastics distribution
Praetura Ventures has been supporting entrepreneurs with more than money since 2011. Click to find out more about how we can help businesses and investors.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Venture - Series Unknown, Seed
- Geography: United Kingdom, Australia, Germany
Investor stats
- Total investments: 167
- Round size: Seed $622k–$4.5M; Venture - Series Unknown $261k–$7.2M
- Lead/follow: 79% lead, 21% follow
- Last fund: Likely still investing — raised $123M in 2022
Portfolio highlights
- Tended — Tended creates advanced solutions to change how people work and improve employee safety across high-risk industries. Through a combination of wearable technology and behavioural science, Tended's main focus is to drive positive behavioural change, which has proven benefits on both an individual and organisational level.Tended'ssolutions are currently improving safety across industry-leading companies in sectors including construction, manufacturing, utilities and logistics.
- Holdson — Holdson is an electrochemical polishing machine tool supplier aiming to address the issue of inconsistent surface finishes on additive manufactured components.The technology is producing intellectual property through patents, providing a competitive advantage in the advanced machinery industry.
- PEAK:AIO — PEAK:AIO delivers software-defined storage for AI, enabling fast, scalable data infrastructure and optimized GPU utilization.
Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Venture - Series Unknown, Seed
- Geography: United Kingdom, United States
Investor stats
- Total investments: 85
- Round size: Seed $1.3M–$4.1M; Venture - Series Unknown $867k–$6.3M
- Lead/follow: 54% lead, 46% follow
Portfolio highlights
- BioCaptiva — BioCaptiva develops liquid biopsy technology devices to diagnose and monitoring to detect cancers.
- Bioliberty — Engineering the future of physical and occupational therapy.
- Earth Blox — Earth Blox provides a platform for analyzing geospatial data through a visual interface for environmental and land analysis. The system enables users to build workflows using satellite imagery and other earth observation datasets without requiring extensive coding knowledge. It supports applications such as deforestation tracking, carbonmonitoring, agriculture assessment, and land use analysis.The platform integrates data sources and processing tools to help users generate insights, automate analyses, and export results for reporting or further use. It also allows collaboration across teams by sharing workflows and outputs within a unified environment. Earth Blox supports organizations working with geospatial intelligence by simplifying access to large-scale environmental data and analysis tools.
Calm/Storm is an exclusive founder network and venture capital firm. We invest in purpose driven founders changing our life & health for the better. Headquartered in Vienna, Austria we invest in early-stage companies all over Europe and the US. We focus on the pre-seed and seed stages but also invest up to Series A.
Show more...Investment focus
- Industry: Health Care, Wellness, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, Germany, Austria
Investor stats
- Total investments: 143
- Round size: Seed $1.1M–$6.3M; Pre-Seed $538k–$2.6M; Series A $7.6M–$18M
- Lead/follow: 8% lead, 92% follow
- Last fund: Likely still investing — raised $25M in 2023
Portfolio highlights
- PROPCORN AI — At PROPCORN, our goal is to harness the power of AI to automatically unlock the full real estate building potential of our customers, enabling them to make faster and more accurate decisions in real-time.
- SquareMind — SquareMind redefines skin exams with Swan, the world's first full-body dermoscopy robot. Automated, seamless, and powered by AI technology.
- aeon.life — Preventive healthcare platform that equips people with personalized insights and expert guidance for proactive whole-body health
Newable: Helping over 20,000 businesses thrive annually with tailored financial products, advice, and flexible workspace solution
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 106
- Round size: Seed $196k–$3.1M; Series A $1.3M–$5.6M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Delta g — Delta g Limited is a quantum technology and gravity gradiometry company. A spin-out from the University of Birmingham our technology has applications in industries as varied as civil engineering, infrastructure, defence, rail, navigation and resource exploration. Experts from science, engineering an
- Weldfast — Weldfast is a manufacturer and supplier of welding consumables, abrasives, chemicals, premium gas equipment, and safety products.
- EarSwitch — Empowering new ways to control and connect with the world through in-ear biometric switch and sensor technology
Pre-seed and seed investors backing 300+ ambitious founders from day one.
Show more...Investment focus
- Industry: Software, FinTech, Internet
- Stage:Seed, Pre-Seed
- Geography: United Kingdom, United States, Italy
Investor stats
- Total investments: 318
- Round size: Seed $229k–$4.1M; Pre-Seed $261k–$2.5M
- Lead/follow: 23% lead, 77% follow
- Last fund: Likely still investing — raised $21M in 2024
Portfolio highlights
- Qureight — Pioneering data curation to solve complex diseases
- Saltroad — Get matched with an experienced HCPC Speech and Language Therapist based on your child's needs, your budget and your schedule. Loved by parents & children.
- Merx — Grow contactability, data quality and customer lifetime value with AI agents on WhatsApp.
Redbus Group is a UK based investment group that invests in early stage ventures and funds or acquires businesses that require restructuring. Redbus Group came into existence as an offshoot of Redbus Film Distribution which was founded in 1997 as a film distribution company. Redbus Film Distribution had rapidly established itself as one of thelargest and most profitable film distributors in the UK. In late 2000 it was sold to Helkon Media AG.Redbus through its subsidiary Filmgroup was the first company in Europe to successfully develop technology to compress and stream moving images over the internet. Between 2000 and 2004 Redbus was the UK's fastest growing company with a compound annual growth rate in-excess of 280%. In 2005 Redbus sold its production and distribution operations to Lionsgate Inc and sold its stake in Lovefilm of which it was co-founder, to Amazon in 2010.Employing an entrepreneurial and disciplined approach, Redbus, either with partners or alone looks for opportunities to leverage off its capital, market knowledge and management resources.
Show more...Investment focus
- Industry: FinTech, E-Commerce, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, United States, Australia
Investor stats
- Total investments: 152
- Round size: Seed $586k–$5.8M; Pre-Seed $323k–$1.6M; Series A $5.4M–$23M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- SOLVE — SOLVE have developed novel transient flow techniques that extend the capabilities of current approaches. SOLVE’s products leverage technology for the efficient collection of data from chemical reactions, as well as predictive computational models tuned based on the collected data. Both the data by itself, as well as the models, are used to informthe reaction conditions and solvent mixtures applied to manufacture chemical compounds at different scales of production.
- Tolemy Bio — The AI-native virtual cell platform for therapeutic development and manufacture.
- Nila Elder Care — Nila acquires independent UK homecare agencies and runs them on our AI platform. Families get care they can count on; owners get a fair exit and a team that's looked after.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Kelvin Capital was founded in 2009 and has since raised a total of over £50million into 28 portfolio companies. We invest venture capital in revenue generating growth companies which have the potential to deliver significant return to their investors. They also invest in companies that require capital to grow their business. For the right companywith the right team, Kelvin Capital provides the investment and the support needed to deliver the true potential of their business.The Kelvin Capital team has a combined 30 years experience of working with new businesses and understands both the challenges and opportunities, which will be encountered during the high growth phase. The team has built up extensive networks, which will be made available to assist and support the portfolio businesses. Kelvin Capital will actively promote the portfolio businesses through its website and social media activities raising their awareness and profile. The entire Kelvin Capital team is focused on the success of their portfolio of businesses.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Manufacturing
- Stage:Seed, Venture - Series Unknown
- Geography: United Kingdom, United States
Investor stats
- Total investments: 108
- Round size: Seed $163k–$1.9M; Venture - Series Unknown $566k–$4.5M
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- Kenoteq — Discover Kenoteq, pioneering the sustainable construction revolution with our innovative, ultra low-carbon building materials.
- Aurora Avionics — Accelerating launch-vehicle development with flexible and modular avionics platforms.
- Sofant Technologies — Sofant is developing a low cost RF MEMS technology that solves power consumption and heat problems in high frequency phased array antenna systems.
Helping individuals and institutions invest in Venture Capital, Infrastructure and Media companies since 1999.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 160
- Round size: Seed $1.7M–$3.9M; Series A $3.2M–$16M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $66M in 2015
Portfolio highlights
- Flyttr — Flyttr is the leader in developing and deploying biosecurity countermeasures against critical pest threats that spread disease, threaten food security.
- Scan.com — Use scan.com to find the best medical imaging centers near you Find an MRI scan, CT scan, X-ray Scan, or other diagnostic imaging scan with scan.com.
- Noggin HQ — The next generation of credit referencing is coming. Look busy.
We turn exceptional individuals into funded founders. We back you first, then give you a bridge to Silicon Valley.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: United Kingdom, United States, India
Investor stats
- Total investments: 478
- Round size: Seed $54k–$6.5M; Pre-Seed $55k–$2.7M; Series A $5.1M–$41M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely actively investing — fresh fund, raised $133M in 2026
Portfolio highlights
- Sourcepulse — Your early warning system for software delivery (YC S23)
- Open Cosmos — Open Cosmos design, build and operate space missions, providing straightforward access to high quality satellite data and insights on a global scale.
- HelmGuard AI — HelmGuard develops an AI-driven trust infrastructure platform for security, compliance, and third-party risk management. The company provides an operational risk infrastructure layer that centralizes fragmented security, compliance, and vendor data into a structured repository. Its platform coordinates autonomous, domain-specific AI agents thatperform continuous data indexing, compliance mapping, automated vendor assessments, and real-time security tracking. HelmGuard includes a risk operating system, a zero-knowledge verification engine for selective disclosure and cryptographic-style proofs, and persona-specific risk intelligence reporting. These capabilities support first-party, third-party, and customer-facing workflows across sectors such as financial services, SaaS, and healthcare. The platform is used by security, risk, and compliance teams to maintain continuous oversight of internal controls, vendor posture, and regulatory obligations while generating tailored, natural-language reports for business stakeholders.
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: Singapore, Australia, United Kingdom
Investor stats
- Total investments: 2377
- Round size: Seed $158k–$4.5M; Pre-Seed $100k–$590k; Series A $4.1M–$29M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fresh fund, raised $7.5M in 2026
Portfolio highlights
- Two — Buy Now, Pay Later for your business customers. Two makes it easy and safe to offer invoice as a payment method on your e-commerce site.
- Forti Foods — The mission of Forti Foods is to enhance communities and change lives beyond the plate by fostering resilience and dignity via sustainable food innovation.
- Neighbourhood — Neighbourhood transform unused spaces in restaurants, hotels and residences, into local hubs for co-working, creating and collaborating.
Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, internationalcorporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 51
- Round size: Seed $551k–$8.5M; Series A $2.6M–$38M; Series B $2.4M–$48M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fresh fund, raised $145M in 2026
Portfolio highlights
- Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
- RapidPulse — Explore RapidPulse for innovative stroke treatments and technologies. Book appointments or learn about our team and clinical trials.
- Epsilogen — IGEM Therapeutics is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.The company's offerings include IgE-based drugs targeting solid tumors, enabling patients to kill parasites which reside in human tissue, also the home of the solid tumor.
Techstart Ventures is a first-cheque investor for extraordinary founders pursuing uncapped global opportunities.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Pre-Seed
- Geography: United Kingdom, Ireland, United States
Investor stats
- Total investments: 206
- Round size: Seed $233k–$4M; Pre-Seed $197k–$1.3M
- Lead/follow: 51% lead, 49% follow
Portfolio highlights
- Go Swag — Branded gifts for people you work with
- Saltroad — Get matched with an experienced HCPC Speech and Language Therapist based on your child's needs, your budget and your schedule. Loved by parents & children.
- Foresight — Foresight turns regulatory change into confident action. Compliance-critical teams see every change that affects their products across chemicals, sustainability, product safety, ESG, and HSE, with the evidence to act.
The FSE Group provides growth finance and support for ambitious UK businesses, helping SMEs start, scale and succeed through tailored funding solutions.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Seed, Debt Financing
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 233
- Round size: Seed $312k–$2.3M; Debt Financing $106k–$862k
- Lead/follow: 73% lead, 27% follow
- Last fund: Likely still investing — raised $88M in 2023
Portfolio highlights
- Spotta — Spotta's smart pest systems help pest control monitor and identify pests. Solutions for hospitality, care homes, agriculture, farming and forestry.
- Amino —
- Process Vision — Process Vision Ltd. Innovation in Natural Gas Monitoring. Revolutionary technology to improve operational excellence.
Transforming UK biotech breakthroughs into impact. o2h Ventures offers SEIS/EIS and growth-stage funds to back visionary teams from seed to clinical success.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United Kingdom, Hungary
Investor stats
- Total investments: 60
- Round size: Seed $603k–$7.3M; Series A $1.9M–$25M; Venture - Series Unknown $1.1M–$2.9M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
- Atelerix — Discover Atelerix's hypothermic hydrogels for reliable cell preservation and ambient temperature shipping. Ensure fresh, viable cell samples.
- Monument Therapeutics — Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.
The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, Italy, Germany
Investor stats
- Total investments: 36
- Round size: Seed $94k–$1.9M; Series A $1.9M–$4.2M
- Lead/follow: 64% lead, 36% follow
Portfolio highlights
- ScubaTx — ScubaTx is a breakthrough organ preservation device organ transplant. The ScubaTx device will leverage world-leading expertise in software design to commercialise a proven but unexploited organ preservation technique, Persufflation. ScubaTx will offer healthcare providers significant net savings, an
- Infex Therapeutics — Infex Therapeutics acquires, develops and licenses innovative drugs to treat pandemic infections
- Monument Therapeutics — Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.
Founded in 2008, Par Equity is a venture capital firm that backs the most innovative, high growth technology companies in the North of the UK. Based in Edinburgh, Par invests across Northern England, Northern Ireland and Scotland.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Venture - Series Unknown, Seed
- Geography: United Kingdom, United States, Brazil
Investor stats
- Total investments: 278
- Round size: Seed $416k–$4.3M; Venture - Series Unknown $113k–$3.4M
- Lead/follow: 53% lead, 47% follow
- Last fund: Likely still investing — raised $122M in 2023
Portfolio highlights
- Fuuse — Fuuse is an electric vehicle charge point management system that enables your chargers to deliver more for you and your drivers.
- PathXL — Cirdan provides highly reliable, innovative LIS & imaging solutions for the acceleration & enhancement of diagnosis, optimized for pathology & clinical lab.
- Skylark Lasers — UniKLasers specialises in single frequency, continuous wave DPSS lasers at mid- to high power. Suitable for Raman, Holography, Interferometry, Microscopy, Metrology, Quantum Technologies, and more
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!A new model for Venture Capital where every founder we back becomes a co-owner of the fund.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 128
- Round size: Seed $1.4M–$16M; Series A $7.9M–$33M; Series B $8M–$73M
- Lead/follow: 30% lead, 70% follow
- Last fund: Likely actively investing — fresh fund, raised $8M in 2026
Portfolio highlights
- ZML — ZML is a production inference stack, purpose-built to decouple AI workloads from proprietary hardware.
- Bios Life — Bios Life is a technology-enabled healthcare company built to empower individuals to proactively manage their cancer risk, redefining personalized cancer screening and survivorship.
- Fractile — Fractile is designing AI compute systems that will enable the next generation of AI scaling: frontier model inference, 25x faster, at 1/10th the cost.
Hoxton Ventures focuses on startups that either disrupt existing industries or invent entirely new market categories. Hoxton typically invests between $500,000 and $5 million into pre-seed, seed, and Series A stage companies, and follows its capital through the life of the company. The firm is based in London and invests all across Europe.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 138
- Round size: Seed $1.9M–$12M; Series A $5M–$28M; Series B $6M–$35M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely actively investing — fresh fund, raised $60M in 2026
Portfolio highlights
- Preply — Looking for a tutor? Preply is the best platform for private online lessons with a flexible payment system and affordable prices. Book your first lesson.
- Behavox — Behavox is an enterprise platform that unifies all types of data into a single data lake, allowing users to query the data and apply machine learning to identify capital markets misconduct and insider threats.Separate Behavox installations form the network defence that aggregates misconduct detection algorithms. The network then uses machinelearning and AI to optimise detection algorithms and suggest new ones. This innovation enables the “brains” to the system to continuously improve and evolve.Complex, high-load and sophisticated engineering is at the core of all the products that Behavox develops to enable deployment at the largest institutions in financial services. They are taking cutting-edge academic research and applying it to enterprise problems that require complex backend engineering with large-scale production footprint.
- Fabrica AI — Fabrica AI offers a revolutionary platform for faster robot development, using custom hardware designs and learned optimal control to increase efficiency while minimizing complexity and cost. With a vision for a future where robot development takes days, not years.
MEIF is an investment firm that operates equity and debt investment towards growth capital. The firm aims to transform the finance landscape for smaller businesses in the Midlands and to realize the region’s potential to achieve economic growth through enterprise. It is a collaboration between the British Business Bank and ten Local EnterprisePartnerships (LEPs) in the West Midlands and East and South East Midlands. MEIF provides over £250m of investment to boost small and medium business (SME) growth in the Midlands.
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Debt Financing, Seed
- Geography: United Kingdom, United States, Portugal
Investor stats
- Total investments: 130
- Round size: Seed $327k–$2.7M; Debt Financing $250k–$1.3M
- Lead/follow: 77% lead, 23% follow
Portfolio highlights
- Doughnotts — Doughnotts is a coffee and doughnut shop.
- School of Coding — School of Coding is affiliated with the reputated org, invites you to apply for sept. intake Explore our courses and start your world-class education.
- Halo X Ray Technologies — HALO X-ray Technologies - next generation X-ray diffraction technology for the aviation security, medical and process control markets.
24Haymarket is an investment network which included several highly-experienced private equity and venture capital investors, seasoned entrepreneurs, and senior operators. Investing up to £5 million in growth companies in the UK and Europe. They invested their own capital in direct alignment with entrepreneurs and actively support their growthagenda and join the board of the companies in which they invest. Since inception in 2011, 24Haymarket has invested in more than 50 high-growth businesses.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 108
- Round size: Seed $736k–$3.7M; Series A $1.6M–$16M; Venture - Series Unknown $107k–$4.3M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- WATR — WATR is the integrated system for real-time water or soil quality monitoring. Our products are robust, reliable, accurate, easy to use and benchmarked for accuracy.
- pixlbio (formerly DefiniGEN) — Generate metabolic disease phenotypes in primary-like human cells using the best-in-class human iPSC differentiation platform. Find out more here!
- Previsico — Discover Previsico's real-time flood forecasting solutions, designed to mitigate risks for businesses and communities worldwide.
Seeding ambitious founders at places like @citymapper, @improbableio,@teamkano, @moo, @songkick,@seedcamp, @transferwise and @zoopla since 1999. Who's next?
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 434
- Round size: Seed $1.5M–$12M; Pre-Seed $1M–$5.1M; Series A $4.2M–$33M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely still investing — raised $500M in 2022
Portfolio highlights
- nPlan — AI that forecasts project outcomes, creates scenarios of the future and helps mitigate risk across single projects and portfolios. Trained on over 750,000 past programmes.
- Stream — Stream is a financial services firm that allows employees to stream their earned wages into their accounts through an instant app. The app allows them to have complete control over when they get paid. It also effectively ends the need for employee advances, loans, and employee stress suffered from short-term, unplanned financial obligations. Thecompany aims to play a key role in reducing the poverty premium and preventing employees from entering cycles of debt caused by overdraft fees, high-interest credit, or payday loans.
- Resolutiion — Resolutiion provides AI-powered software for managing commercial conflict, delivery risk, and business relationship performance. The platform supports organizations with dispute detection, workflow automation, contract monitoring, issue resolution, and operational risk management across customers, suppliers, workforce teams, and commercialpartnerships. Its system uses AI-driven analysis to identify relationship friction, monitor delivery performance, and support structured resolution processes. Resolutiion also provides commercial intelligence tools, reporting, and collaboration features for enterprise delivery and governance management.
Syncona is a FTSE250 company focused on founding, building and funding healthcare companies to deliver transformational treatments to patients in areas of high unmet need.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Series B, Seed
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 75
- Round size: Seed $1.9M–$17M; Series A $13M–$87M; Series B $29M–$156M
- Lead/follow: 59% lead, 41% follow
Portfolio highlights
- Apini Therapeutics — Apini is a creating novel small chemical two most prevalent types of inflammatory bowel disease.
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
- Re-Aim Therapeutics — Re‑Aim Therapeutics is a UK‑based biotech start‑up developing functional cures for T cell–mediated autoimmune diseases by selectively depleting pathogenic T‑cell subsets. Its lead asset, REA‑001, is a monoclonal antibody designed to potently and precisely eliminate disease‑causing type‑17 T cells, aiming to reset the immune system and achievedurable, treatment‑free remission in multiple autoimmune conditions.
As a team, we have a passion for science and its potential to drive change. Through our expertise and our position in one of the country's most powerful science and technology ecosystems, we're able to identify and support the most promising entrepreneurs in knowledge intensive businesses and help them achieve their vision.With our financial backing and expert guidance, we're excited to enable the pioneers in life sciences and deep tech to create world-leading companies whose unique ideas bring financial success and global impact.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Seed
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 118
- Round size: Seed $2M–$31M; Series A $2.6M–$73M; Series B $8.2M–$61M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely actively investing — fresh fund, raised $332M in 2025
Portfolio highlights
- Immutrin — Immutrin is a biotechnology company developing next‑generation antibody therapies designed to clear systemic amyloid deposits and reverse amyloidosis, this company lead asset targets ATTR cardiomyopathy, a severe and progressive form of amyloidosis, and its antibody represents a potential best‑in‑class treatment engineered to selectively andspecifically remove established amyloid fibrils.
- Trent AI — Trent AI creates AI applications and agent security management software. It aids in risk assessment and mitigation in systems utilizing autonomous or semi-autonomous software agents. The company's technology monitors agent activity across APIs, tools, and workflows. It continuously assesses security posture via iterative scanning andcontextual understanding of system architectures.
- TRIMTECH Therapeutics — Transformative treatments for CNS and inflammatory disorders by selectively destroying disease-causing protein aggregates
The opportunity for institutional investors to access leading UK early stage healthtech businesses
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United Kingdom, United States, Israel
Investor stats
- Total investments: 153
- Round size: Seed $501k–$4.2M; Series A $3.4M–$13M; Venture - Series Unknown $2.4M–$14M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $2.8M in 2014
Portfolio highlights
- TidalSense — CRiL was formed in April 2013 specifically to develop innovative medical devices to diagnose and manage respiratory conditions. They have been building a platform technology, N-Tidal, based on the measurement and analysis of tidal breathing CO2 throughout the entire breath.
- Qkine — Growth Factors made for stem cells Animal-free We control every step of protein manufacture ensuring all our products are completely animal-free Total transparency Stringent purity and bioactivity testing data for all proteins - know what you are giving your cells Protein innovation Our R&D team
- FundamentalVR — Solutions for knowledge acquisition and skills development for any interactive medium
Maven is one of the UK's leading private equity and investment firms. We provide essential capital and expertise to help businesses unlock their potential.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Venture - Series Unknown, Seed, Private Equity
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 217
- Round size: Seed $792k–$5M; Private Equity $981k–$15M; Venture - Series Unknown $648k–$8.1M
- Lead/follow: 75% lead, 25% follow
- Last fund: May invest from a new fund soon — raised $132M in 2019
Portfolio highlights
- KubeNet — We are KubeNet - a multi-award winning technology solutions provider based in Glasgow. Whether it's Managed IT, IT Support, Cloud, Connectivity, Voice or Cyber Security, we're by your side as your trusted technology partner.
- Tixserve — Secure, Trackable, Interactive Digital Tickets for Live Events
- ReadyGo Diagnostics — ReadyGo Diagnostics has invented a novel “Diagnostic Pen”. Low cost, intuitive to use from the raw sample, the ReadyGo Pen will be a game-changer in the newly emerging consumer diagnostics market, offering a yes/no answer in minutes, based on molecular analysis.
Empirical Ventures is a specialist VC and venture builder backing the world's boldest early-stage deep-tech and life-science companies, built by scientists.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Seed, Pre-Seed
- Geography: United Kingdom
Investor stats
- Total investments: 39
- Round size: Seed $924k–$5.8M; Pre-Seed $1.1M–$1.6M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- BoobyBiome — BoobyBiome harnesses breast milk microbiome science to develop products to improve infant health
- Optera — Optera are a leading specialist structural repair company located in the West Midlands, which provides the ideal base for giving national coverage. Optera offer specialist structural solutions to problems widely encountered within the domestic property sector and are engaged daily to provide solutions to the Insurance market place.
- Nuclear Turbine — Delivering advanced nuclear generation for markets where the cost of electricity is a growth constraint.
Health Care VC funding in United Kingdom at a glance
Stats across 6.5k deals from 3.3k investors.
Access all 3347 VC funds in United Kingdom Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care VC Funds in United Kingdom investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 3347 VC funds investing in United Kingdom Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!